Delivery Order SPE2D021DA002-SPE2D325F277V
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of Isentress 400 mg tablets. The contract, valued at $1,381.17, has an ultimate completion date of April 30, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) SPE2DB program, valued at up to $499,999,999, which allows the DLA to issue delivery orders for a comprehensive...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,381.17 firm fixed-price contract is for the supply of ISENTRESS 400 MG tablets, and has a completion date of June 3, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,381.17, is for the delivery of Isentress 400 mg tablets. This order is part of a larger indefinite delivery contract, SPE2DB, that DMS Pharmaceutical Group holds with DLA, valued up to $4,999,999 through 2025. Through this IDV, DMS Pharmaceutical provides a wide...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product Isentress 400 mg tablet. The order has a potential value of $1,336.79 and a completion date of April 4, 2023. DMS Pharmaceutical Group holds multiple federal contracts and Indefinite Delivery Vehicles (IDVs) to supply pharmaceuticals and medical products in support of military treatment facilities...
- This federal contract award, valued at $13,811.70, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Isentress 400 mg tablets, with a completion date of June 25, 2024. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product Isentress 400 mg Tablet. The potential value of this order is $2,541.64 and the period of performance runs through February 23, 2022. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds various federal contracts and Indefinite Delivery Vehicles (IDVs) to supply pharmaceuticals...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide the pharmaceutical product Isentress 400 mg tablet. The $1,162.82 contract has a completion date of August 12, 2021. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds multiple federal contracts and indefinite delivery vehicles with the Defense Logistics Agency to supply a wide range of...
- The Defense Logistics Agency Troop Support Medical has awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 400 mg Isentress tablets. The one-year contract has a potential value of $1,270.82 and was awarded on September 14, 2022, with a completion date of September 15, 2022. DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that holds various contracts with the Defense Logistics Agency to supply a wide range of...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract has a ceiling value of $9,238.18 and covers the delivery of the pharmaceutical product Isentress 400 mg tablets. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a wide range of branded and generic prescription drugs, over-the-counter...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide 400 mg Isentress tablets. This delivery order, valued at $1,270.82, was issued under a larger indefinite delivery contract held by DMS Pharmaceutical Group with the Defense Logistics Agency to supply pharmaceuticals and medical products in support of military treatment facilities worldwide. The contract does not have a...
- SPE2D021DA002Indefinite Delivery Contract
- SPE2D021DA002-SPE2D325F277VDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was awarded a delivery order on July 30, 2025, for 60 tablets of Isentress 400 mg with a ceiling value of $6,280.86. This firm fixed-price delivery order, which is due for completion by July 31, 2025, was issued by the Defense Logistics Agency's Medical Supply Chain division without a set-aside designation. The contract represents a continuation of DMS Pharmaceutical Group's role as a key supplier within the federal pharmaceutical distribution network, leveraging its underlying Indefinite Delivery Contract with the Defense Logistics Agency valued at $499.99 million through November 2026. Isentress (raltegravir) is an integrase inhibitor antiretroviral medication used in the treatment of human immunodeficiency virus (HIV) infection. This delivery order supports the Department of Defense's pharmaceutical supply requirements for military healthcare facilities. DMS Pharmaceutical Group has established itself as a critical partner in the Defense Logistics Agency's pharmaceutical procurement strategy, consistently competing for and securing delivery orders across a diverse portfolio of branded and generic prescription drugs, biologics, and medical consumables to meet the medical supply needs of military health systems nationwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.3k | 7/30/25 |